Authors: Muehlenweg, B Sperl, S Magdolen, V Schmitt, M Harbeck, N

Citation: B. Muehlenweg et al., Interference with the urokinase plasminogen activator system: a promising therapy concept for solid tumours, EXPERT OP B, 1(4), 2001, pp. 683-691

Authors: Sperl, S Bergner, A Sturzebecher, J Magdolen, V Bode, W Moroder, L

Citation: S. Sperl et al., Urethanyl-3-amidinophenylalanine derivatives as inhibitors of factor Xa. X-ray crystal structure of a trypsin/inhibitor complex and modeling studies, BIOL CHEM, 381(4), 2000, pp. 321-329

Authors: Schmitt, M Wilhelm, OG Reuning, U Kruger, A Harbeck, N Lengyel, E Graeff, H Gansbacher, B Kessler, H Burgle, M Sturzebecher, J Sperl, S Magdolen, V

Citation: M. Schmitt et al., The urokinase plasminogen activator system as a novel target for tumour therapy, FIBRINOL PR, 14(2-3), 2000, pp. 114-132

Authors: Sperl, S Jacob, U de Prada, NA Sturzebecher, J Wilhelm, OG Bode, W Magdolen, V Huber, R Moroder, L

Citation: S. Sperl et al., (4-Aminomethyl)phenylguanidine derivatives as nonpeptidic highly selectiveinhibitors of human urokinase, P NAS US, 97(10), 2000, pp. 5113-5118

Authors: Zeslawska, E Schweinitz, A Karcher, A Sondermann, P Sperl, S Sturzebecher, J Jacob, U

Citation: E. Zeslawska et al., Crystals of the urokinase type plasminogen activator variant beta c-uPA incomplex with small molecule inhibitors open the way towards structure-based drug design, J MOL BIOL, 301(2), 2000, pp. 465-475